Lombardia Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,308
Closed -$401K 187
2016
Q2
$401K Sell
3,308
-13,004
-80% -$1.48M 0.03% 173
2016
Q1
$1.76M Buy
16,312
+12,658
+346% +$1.31M 0.09% 149
2015
Q4
$375K Hold
3,654
0.02% 173
2015
Q3
$341K Hold
3,654
0.02% 172
2015
Q2
$356K Sell
3,654
-133,471
-97% -$13.4M 0.01% 185
2015
Q1
$13.8M Sell
137,125
-41,829
-23% -$4.25M 0.41% 94
2014
Q4
$18.7M Sell
178,954
-19,090
-10% -$2.01M 0.54% 78
2014
Q3
$21.1M Buy
198,044
+18,317
+10% +$1.9M 0.62% 60
2014
Q2
$18.8M Buy
179,727
+3,715
+2% +$375K 0.51% 76
2014
Q1
$17.3M Buy
176,012
+5,018
+3% +$465K 0.47% 80
2013
Q4
$15.7M Sell
170,994
-1,714
-1% -$158K 0.45% 89
2013
Q3
$15M Sell
172,708
-16,168
-9% -$1.45M 0.48% 80
2013
Q2
$16.2M Buy
+188,876
New +$16M 0.54% 75

Other funds holding JNJ

Lombardia Capital Partners's JNJ Position: Q3 2016 in Review

Lombardia Capital Partners sold out of Johnson & Johnson (JNJ) in Q3 2016, closing a stake of 3,308 shares — an estimated $401K sold.

Lombardia Capital Partners first reported a position in JNJ in Q2 2013 and held it in 13 quarters. The position peaked at $21.1M in Q3 2014. 2,227 funds tracked by Wall St. Rank hold JNJ as of Q3 2016.

  • Lombardia Capital Partners reported no remaining Johnson & Johnson position as of Q3 2016 after selling out during the quarter.
  • Lombardia Capital Partners sold 3,308 Johnson & Johnson shares in Q3 2016, an estimated $401K.
  • Lombardia Capital Partners first reported a position in Johnson & Johnson in Q2 2013 and held it in 13 quarters.
  • Lombardia Capital Partners's Johnson & Johnson position peaked at $21.1M in Q3 2014.
  • 2,227 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2016.

Based on Lombardia Capital Partners's 13F filing for Q3 2016, filed 9 Nov 2016.